<DOC>
	<DOCNO>NCT01926496</DOCNO>
	<brief_summary>The purpose study compare risk develop squamous skin cancer ( SCC ) type cancer treatment AKs ingenol mebutate gel imiquimod cream . Subjects randomise treatment ingenol mebutate imiquimod receive second treatment cycle treatment first treatment clear AKs . Subjects follow period three year ( 36 month ) first treatment</brief_summary>
	<brief_title>Risk Squamous Cell Carcinoma Skin Areas Treated With Ingenol Mebutate Gel , 0.015 % Imiquimod Cream , 5 %</brief_title>
	<detailed_description />
	<mesh_term>Keratosis</mesh_term>
	<mesh_term>Keratosis , Actinic</mesh_term>
	<mesh_term>Imiquimod</mesh_term>
	<criteria>1 . Signed Informed Consent Form ( ICF ) prior trialrelated procedure 2 . Subjects 5 9 clinically typical , visible discrete AKs within contiguous 25 cmÂ² treatment area face scalp . 3 . Subject least 18 year age 4 . Female subject must either : 1 . Nonchildbearing potential , , 2 . Childbearing potential , provide confirm negative urine pregnancy test 5 . Female subject childbearing potential must willing use highly effective method contraception ( Pearl index &lt; 1 % ) 1 . Location select treatment area : periorbital skin perioral skin/around nostril within 5 cm incompletely heal wound within 10 cm suspect BCC SCC neoplasia 2 . Selected treatment area lesion atypical clinical appearance ( e.g. , hypertrophic , hyperkeratotic cutaneous horn ) . 3 . History SCC , BCC , malignant melanoma neoplasia select treatment area . 4 . History evidence skin condition trial indication would interfere evaluation trial medication select treatment area 5 . Use ingenol mebutate and/or imiquimod within 5 cm select treatment area within 2 year prior Screening ( Visit 1 ) 6 . Organ transplant recipient 7 . Immunosuppressed subject ( example HIV patient ) 8 . Female subject breastfeed . 9 . Subjects institutionalised court order local authority 10 . In opinion investigator , subject unlikely comply Clinical Study Protocol ( e.g . alcoholism , drug dependency psychotic state )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>